Stock data
BioCardia, Inc. (BCDA)
BioCardia, Inc. (BCDA) reported net income of -US$8.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$8.28M | -US$8.23M | — |
| 2024 | — | — | -US$8.00M | -US$7.95M | — |
| 2023 | — | — | -US$11.64M | -US$11.57M | — |
| 2022 | — | — | -US$11.90M | -US$11.91M | — |
| 2021 | — | — | -US$12.63M | -US$12.62M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$1.61M | — |
| 2026-03-31 | — | -US$2.26M | — |
| 2025-12-31 | — | -US$1.98M | — |
| 2025-09-30 | — | -US$1.48M | — |
| 2025-06-30 | — | -US$2.05M | — |
| 2025-03-31 | — | -US$2.71M | — |
| 2024-12-31 | — | -US$2.30M | — |
| 2024-09-30 | — | -US$1.74M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.